At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CURE Direxion Daily Healthcare Bull 3X ETF
Pre-Mkt 09-24 06:14:37 EDT
130.33
-2.57
-1.93%
High135.40Low129.00Vol39.57K
Open133.17D1 Closing132.90Amplitude4.82%
Mkt Cap169.43MTradable Cap169.43MTotal Shares1.30M
T/O5.21MT/O Rate3.04%Tradable Shares1.30M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT
Reuters  ·  09-23 16:21
Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT
RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
TIPRANKS  ·  09:45
RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
Eli Lilly & Co. Stock Underperforms Wednesday When Compared to Competitors
Dow Jones  ·  04:31
Eli Lilly & Co. Stock Underperforms Wednesday When Compared to Competitors
Eli Lilly Price Target Maintained with a $1250.00/Share by TD Cowen
Dow Jones  ·  09-22 23:11
Eli Lilly Price Target Maintained with a $1250.00/Share by TD Cowen
Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire
Dow Jones  ·  09-22 21:47
Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)
TIPRANKS  ·  09-22 21:30
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)
Lucid Diagnostics advances Medicare reimbursement and coding infrastructure
TIPRANKS  ·  09-22 21:29
Lucid Diagnostics advances Medicare reimbursement and coding infrastructure
Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up
Reuters  ·  09-22 21:06
Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up
Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss
Stock News  ·  09-22 21:00
Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss
Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.
Dow Jones  ·  09-22 20:22
Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.
Eli Lilly and Company Breaks Ground on $6.5 Billion Houston Manufacturing Site
MT Newswires Live  ·  09-22 05:55
Eli Lilly and Company Breaks Ground on $6.5 Billion Houston Manufacturing Site
Eli Lilly: Breaks Ground on Fifth U.S. API Manufacturing Site in Houston
THOMSON REUTERS  ·  09-22 05:44
Eli Lilly: Breaks Ground on Fifth U.S. API Manufacturing Site in Houston
Eli Lilly: Houston Facility to Manufacture Active Pharmaceutical Ingredients for Medicines Like Foundayo
THOMSON REUTERS  ·  09-22 05:44
Eli Lilly: Houston Facility to Manufacture Active Pharmaceutical Ingredients for Medicines Like Foundayo
Sector Update: Healthcare
MT Newswires Live  ·  09-22 03:21
Sector Update: Healthcare
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients taking Foundayo
TIPRANKS  ·  09-22 01:05
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients taking Foundayo
Top Midday Stories: Paramount Skydance Settles With US States to Pave Way for Warner Bros. Deal; Anthropic Now Eyeing November IPO
MT Newswires Live  ·  09-21 23:39
Top Midday Stories: Paramount Skydance Settles With US States to Pave Way for Warner Bros. Deal; Anthropic Now Eyeing November IPO
Weight-Loss Drug Giant Sheds 13,000 Positions
Deep News  ·  09-21 23:30
Weight-Loss Drug Giant Sheds 13,000 Positions
Novo Nordisk Says New Obesity Drug Outperformed Lilly's Zepbound in Phase 3 Trial
Dow Jones  ·  09-21 22:52
Novo Nordisk Says New Obesity Drug Outperformed Lilly's Zepbound in Phase 3 Trial
Novo Stock (NVO) Sinks Despite Beating Eli Lilly in New CagriSema Obesity Trial
TIPRANKS  ·  09-21 21:52
Novo Stock (NVO) Sinks Despite Beating Eli Lilly in New CagriSema Obesity Trial
Oura Files for Initial Public Offering on Nasdaq
MT Newswires Live  ·  09-21 19:48
Oura Files for Initial Public Offering on Nasdaq

Introduction

Company Name.
Direxion Daily Healthcare Bull 3X ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified.
Issue price:
--